The long-term efficacy and tolerability of donepezil in patients with vascular dementia Academic Article uri icon

Overview

MeSH Major

  • Cholinesterase Inhibitors
  • Dementia, Vascular
  • Indans
  • Piperidines

abstract

  • These data suggest that donepezil improves cognition for up to 54 weeks in patients with VaD. Patients initiating donepezil in this extension study did not perform as well on the primary outcome measure as those initiating donepezil in the double-blind study.

publication date

  • March 2010

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1002/gps.2340

PubMed ID

  • 19623601

Additional Document Info

start page

  • 305

end page

  • 13

volume

  • 25

number

  • 3